Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2023)
Tyra Biosciences (TYRA) reported Interest Coverage Ratio of 762.57 for Q2 2023, up 35.74% on a YoY basis from 561.77 in Q2 2022, and up 94.68% quarter-over-quarter from 14334.0 in Q1 2023.
Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2023) Analysis & Trends
Tyra Biosciences has reported Interest Coverage Ratio for 4 years, with the latest figure at 762.57 in Q2 2023.
- For the quarter ending Q2 2023, Interest Coverage Ratio rose 35.74% year-over-year to 762.57; the trailing twelve-month figure through Mar 2024 stood at 4187.29 (down 272.68% YoY), and the FY2023 full-year result was 2049.87, down 73.93% from the prior year.
- Interest Coverage Ratio for Q2 2023 stood at 762.57, up from 14334.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 333.14 in Q3 2020, with the low at 14334.0 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 2440.39 across 4 years, with a median of 948.29 in 2021.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 86.25% — and 2023, when it plunged 866.29%.
- Tyra Biosciences' Interest Coverage Ratio stood at 612.83 in 2020, then tumbled by 440.22% to 3310.67 in 2021, then soared by 86.25% to 455.09 in 2022, then sank by 67.56% to 762.57 in 2023.
- The last three Interest Coverage Ratio figures came in at 762.57 (Q2 2023), 14334.0 (Q1 2023), and 455.09 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -762.57 |
| Mar 31, 2023 | -14,334.00 |
| Dec 31, 2022 | -455.09 |
| Sep 30, 2022 | -2,729.00 |
| Jun 30, 2022 | -1,186.77 |
| Mar 31, 2022 | -1,483.40 |
| Dec 31, 2021 | -3,310.67 |
| Sep 30, 2021 | -948.29 |
| Jun 30, 2021 | -688.50 |
| Dec 31, 2020 | -612.83 |
| Sep 30, 2020 | -333.14 |